egfr t790m Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

M.D. Anderson Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmetastasis

I am/have/hadliver metastases

I am/have/hadnon-small cell lung cancer

I am/have/hadstage iiib lung cancer ajcc v8

I am/have/hadstereotactic body radiation therapy

I am/have/hadEGFR

I am/have/hadlung cancer

I am/have/hadrecurrent nsclc

I am/have/hadcarcinoma

I am/have/hadstage iv lung cancer ajcc v8

I am/have/hadlocal ablative therapy

I am/have/hadsystemic therapy

I am/have/hadlung carcinoma

I am/have/hadliver metastasis

I am/have/hadegfr t790m

I am/have/hadperiodic abstinence

I am/have/hadpd-l1

I am/have/hadstage ivb lung cancer ajcc v8

I am/have/haddeletion mutation

I am/have/hadrecurrent non-small cell lung cancer

added new label for I am/have/had

more

I am looking for

I am looking forgrowth factor

I am looking forblockade

I am looking fortyrosine

I am looking forosimertinib

I am looking forhemoglobin a1c

I am looking forhba1c

I am looking forsapanisertib

I am looking fortotal bilirubin

I am looking foralisertib

I am looking forglycosylated hemoglobin

I am looking forkinase inhibitor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Osimertinib With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

This phase Ib trial studies the side effects and best dose of alisertib or sapanisertib, in combination with osimertinib, in treating patients with EGFR mutated stage IIIB or IV non-small cell lung cancer that remains despite treatment with osimertinib (osimertinib resistant). Osimertinib, alisertib, and sapanisertib may stop the growth of …

metastasis

liver metastases

non-small cell lung cancer

stage iiib lung cancer ajcc v8

stereotactic body radiation therapy

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.